ANI Pharmaceuticals Inc (ANIP) stock news · P/E 16, rev $883.4M
ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on US.
This ANIP news page leads with what ANI Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for ANIP yet. We will not pad this page with generic market recap.
Latest reported ANIP revenue for 2025-12-31 was $883.4M. Net income was $78.3M. Revenue was up 43.8% from 2024-12-31 to 2025-12-31. ANIP currently screens at market cap $1.41B and trailing P/E 15.7.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ANIP stock page; for the tape open the quote page.
ANIP stock news FAQ
What are ANIP's latest revenue and net income?
Latest cached ANI Pharmaceuticals Inc (ANIP) revenue for Dec 31, 2025 was $883.4M. Net income was $78.3M. Statements: https://lician.com/financials/anip
How did ANIP revenue change from the prior cached period?
Cached ANI Pharmaceuticals Inc (ANIP) revenue was up 43.8% from $614.4M (Dec 31, 2024) to $883.4M (Dec 31, 2025). Statements: https://lician.com/financials/anip
What is ANIP's P/E ratio?
ANI Pharmaceuticals Inc (ANIP) trailing P/E is 15.7 on the latest cached fundamentals snapshot.
What is ANIP's market cap?
ANI Pharmaceuticals Inc (ANIP) market cap is $1.41B on the latest cached fundamentals snapshot.
What kind of company is ANIP?
ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on US.
Where is ANIP stock news listed?
Cached stock news for ANI Pharmaceuticals Inc (ANIP) is listed at https://lician.com/news/anip. Filings: https://lician.com/sec/anip
Not investment advice.